Z
ZEVRA THERAPEUTICS INC.
NASDAQ: ZVRA (Zevra Therapeutics, Inc.)
最近更新时间: 12小时之前8.66
0.23 (2.73%)
| 前收盘价格 | 8.43 |
| 收盘价格 | 8.41 |
| 成交量 | 1,473,552 |
| 平均成交量 (3个月) | 517,787 |
| 市值 | 473,525,312 |
| 价格/销量 (P/S) | 14.10 |
| 股市价格/股市净资产 (P/B) | 9.93 |
| 52周波幅 | |
| 利润日期 | 11 Aug 2025 - 15 Aug 2025 |
| 营业利益率 (TTM) | -128.01% |
| 稀释每股收益 (EPS TTM) | -2.28 |
| 季度收入增长率 (YOY) | -6.80% |
| 总债务/股东权益 (D/E MRQ) | 152.01% |
| 流动比率 (MRQ) | 2.53 |
| 营业现金流 (OCF TTM) | -69.67 M |
| 杠杆自由现金流 (LFCF TTM) | -36.36 M |
| 资产报酬率 (ROA TTM) | -31.03% |
| 股东权益报酬率 (ROE TTM) | -207.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Zevra Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
3.4
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 3.38 |
|
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.62% |
| 机构持股比例 | 62.37% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Woodline Partners Lp | 31 Mar 2025 | 4,615,625 |
| Nantahala Capital Management, Llc | 31 Mar 2025 | 1,471,936 |
| Aigh Capital Management Llc | 31 Mar 2025 | 1,438,109 |
| Altium Capital Management Llc | 31 Mar 2025 | 1,287,333 |
| 683 Capital Management, Llc | 31 Mar 2025 | 1,225,834 |
| Velan Capital Investment Management Lp | 31 Mar 2025 | 665,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (Cantor Fitzgerald, 188.68%) | 购买 |
| 25.00 (Canaccord Genuity, 188.68%) | 购买 | |
| 中 | 22.00 (154.04%) | |
| 低 | 18.00 (Citizens Capital Markets, 107.85%) | 购买 |
| 平均值 | 22.00 (154.04%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 7.98 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Cantor Fitzgerald | 14 May 2025 | 25.00 (188.68%) | 购买 | 8.14 |
| 12 Mar 2025 | 25.00 (188.68%) | 购买 | 7.92 | |
| Canaccord Genuity | 13 Mar 2025 | 25.00 (188.68%) | 购买 | 7.94 |
| Guggenheim | 13 Mar 2025 | 22.00 (154.04%) | 购买 | 7.94 |
| HC Wainwright & Co. | 13 Mar 2025 | 20.00 (130.95%) | 购买 | 7.94 |
| Citizens Capital Markets | 12 Mar 2025 | 18.00 (107.85%) | 购买 | 7.92 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合